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BODY WATER COMPARTMENTS DURING BED REST:
EVALUATION OF ANALYTICAL METHODS
H. L. Young, L. Juhos, B. L. Castle, J. Yusken, and J. E. Greenleaf
Ames Research Center
SUMMARY
Nine healthy young men, ages 21 to 25, were studied to determine the reproducibility and
interchangeability of the use of (a) radio-iodinated human serum albumin ( I 1 3 1 ) and Evans Blue
dye for estimating plasma volume, (b) sodium bromide for extracellular fluid volume, and (c)
deuterium oxide (D2O) for total body water volume. All subjects were tested in a semibasal
condition and allowed to rest for at least 30 min after arriving at the laboratory. Evans Blue and
I 1 3 ' were administered intravenously and NaBr and D2O by oral ingestion. Venous blood samples
were collected for analysis at various intervals after the tracers were administered. For the measure-
ment of plasma volume, a comparison was made between the 10-min postinjection blood sample
and the 0-min value extrapolated from the 10-, 20-, 30-, and 60-min samples. For NaBr and D2O
spaces, a comparison was made between the three 3-hr postingestion blood samples and the 0-min
value extrapolated from the 2-, 3-, 5-, and 8-hr samples. The results indicate (a) there was uniform
distribution of I 1 3 ' and Evans Blue dye 10 min after injection and of NaBr and D2O 3 hours after
oral ingestion; (b) the buildup of residual tracer did not interfere appreciably with the measurement
of either I 1 3 ' or Evans Blue spaces when they were administered at four equal intervals over 8 days
or three times in 15 days; and (c) the buildup of background tracer after ingestion of NaBr and D2 O
once per week for three consecutive weeks did not affect the accuracy of the measurement. Average
interindividual variability (±SE) over a 3-week period was ±155 ml for I 1 3 1 space, ±146 ml for
Evans Blue space, ±310 ml for bromide space, and ±2,300 ml for total body water space. It was
found that (a) I 1 3 1 and Evans Blue may be used interchangeably for estimating plasma volume and
one 10-min equilibration sample gives results comparable to those obtained using the 0-min extrapo-
lation of multiple blood samples, and (b) for estimating bromide and D2 O spaces, one 3-hr equili-
brium blood sample gives results similar to the extrapolation of multiple samples.
INTRODUCTION
Loss of total water and reduction in plasma volume have been reported in astronauts who have
returned from spaceflight and also in subjects during prolonged bed rest. The mechanism of these
changes is unknown, but it appears to result from reduced hydrostatic pressure in the circulatory
system. To understand this mechanism, the accuracy of various analytical techniques for deter-
mining body fluid compartments must first be investigated.
Numerous analytical methods have been developed to measure the volumes of plasma (PV),
extracellular fluid (ECF), and total body water (TBW) in man. All these methods are based on the
tracer dilution principle. However, the results from different techniques for measuring any one fluid
compartment show some discrepancies, due partly to the inherent errors of the chemical analysis
but mostly to the differences in distribution of the various tracers in the body.
To obtain simultaneous, accurate measurements of the changes in plasma volume, extracellular
fluid volume, and total body water volume, the analytical methods should not interfere with each
other and should fulfill the following general requirements: The tracer should be clinically accepta-
ble for human use; it should be chemically stable, nontoxic, and relatively well characterized
metabolically and physiologically; and it should be measurable with high accuracy and precision.
The samples collected after the tracer(s) is administered should be easily accessible and convenient
to analyze either immediately after withdrawal or after storage. In addition, the radioactive tracer
should have a low radiation energy to minimize health hazards and a short biological half-life to
afford multiple repeated measurements without a buildup of radiation, and there should be no loss
in measurement accuracy while the sample-to-background ratio decreases to less than 2:1.
The selection of a method for measuring total body water is comparatively simple. The
nonradioactive isotope, deuterium oxide, provides the advantages of an isotopic method, with good
analytical accuracy but without the health hazard of radioactivity. Thus, the method using deute-
rium oxide fulfills the above requirements, but the analytical procedure is more tedious than when
radioactive tritium is used (refs. I and 2).
Selecting a tracer for the determination of extracellular fluid volume is more difficult. To date,
no single tracer is accepted unequivocally as ideally suited for this measurement. Substances com-
monly used to measure ECF may be classified into two groups of compounds (refs. 3—5). The first
group of compounds (thiocyanates and bromides) estimates the volume occupied by the chloride
ions in the body. The volume measured by these compounds is somewhat greater than the true
extracellular space since the thiocyanate and bromide ions remain in the gastrointestinal tract and
also enter the red blood cells (ref. 4). The second group of substances commonly used'for this
purpose include inulin, sucrose, thiosulfate, and sulfate. These substances do not remain in the
gastrointestinal tract and do not penetrate the connective tissues. Thus, the "true" extracellular
fluid volume probably lies between the bromide and inulin spaces (ref. 6). For the present study,
the bromide space was selected for estimating extracellular fluid volume because both radioactive
and nonradioactive bromides were available as tracers and because the analytical procedure for
determining nonradioactive bromide is relatively simple and accurate. The short half-life of Br8 2
(36 hours) and its simple counting technique make it an attractive choice for future studies.
Two tracers are most commonly used for measuring plasma volume: radio-iodinated human
serum albumin (I1 3 1) and the azo-dye Evans Blue (T-1824) (refs. 7—11). Both substances are
preferentially bound to plasma albumin and distributed within the plasma albumin space. Simul-
taneous measurement of PV with these two tracers has shown comparable results (refs. 8 and 9).
In the present study, I 1 3 1 and Evans Blue were chosen to determine the plasma volume;
. sodium bromide and deuterium oxide were selected to measure the volumes of extracellular fluid
and total body water, respectively. Although these tracers have often been used by different
investigators, detailed information on the influence of one tracer on another during the simul-
"taneous measurements of three water compartments, and on the effect of tracer accumulation on
the subsequent determination is unavailable but necessary to obtain accurate and reproducible
results on repeated measurements of body fluids. Therefore, the purpose of this study is to compare
the interchangeability of I 1 3 1 with Evans Blue for measuring plasma volume; to determine the
reproducibility of bromide and deuterium oxide measurements of ECF and TBW spaces, respec-
tively; to determine the effect of I 1 3 ' buildup on the measurement of Evans Blue space; and to
determine the effect of bromide and deuterium oxide buildup on the measurement of ECF and
TBW spaces, respectively.
PROCEDURE AND METHODS
Nine healthy men, ages 21 to 25, were instructed to abstain from food after 10 PM the night
before the scheduled determination but without restriction of water intake. They arrived at the
laboratory at 8 AM, were then weighed and allowed to rest in bed for 30 min. A urine sample was
collected and a 10-ml preinjection control blood sample was taken without stasis from the ante-
cubital vein with a 21 guage (21G) needle. The subjects remained in the horizontal posi-
tion during the entire 2-hr period of the plasma volume measurement and during the first 3 hours
of the extracellular fluid volume and the total body water measurements. After the 3-hr blood
sample was withdrawn for the measurements of ECF and TBW, the subjects were allowed to
sit up in bed. Food was withheld from the subjects during the 8-hr test, but 300 ml of water was
given to provide sufficient urinary volume for accurate isotope measurements.
Plasma Volume
The plasma volume was determined by either one or both tracer methods with I13 1 a or Evans
Blue dye."3 All subjects participating in the plasma volume experiments were required to take 10
drops of Lugols solution in water daily 3 days before and also on the day of measurement to block
the uptake of I1 3' by the thyroid gland.
The radioactive iodine technique was similar to that of Crispell, Porter, and Nieset (ref. 11)
with the following modifications: A zero time blood sample was drawn with a 21G needle, and
through the same needle approximately 1.5 ml of I 1 3 ' (specific activity 5.0 /uCi per 15 mg serum
albumin in 0.45 percent sodium chloride, Lot #L812031) was injected. The syringe containing I13!
and the needle were carefully weighed before the injection. After the injection of I1 3 ', the needle
was wiped clean and the syringe and needle were weighed again immediately. The exact amount of
I 1 3 1 injected was determined by the difference in weight of the syringe and needle before and after
the injection. Blood samples were taken from the arm opposite that of the injection 10, 20, 30, 60,
90, and 120 min after injection. After the needle was disconnected, the blood sample was delivered
slowly from the syringe into a sodium-heparinized glass tube and was mixed continuously on a
mechanical rotator for approximately 5 min. The plasma was separated from the red cells by
centrifugation-(at approximately 800 G for 10 min) and 2 ml of plasma was transferred to a count-
ing tube. The radioactivity of the plasma was counted in a Packard Tri-Carb series 314E liquid
scintillation gamma spectrometer. Several I 1 3 ' standards were prepared daily by diluting a weighed
amount of commercial I 1 3 1 solution in 500 ml of 0.9 percent sodium chloride solution. Two-mi
volumes of 0.9 percent sodium chloride solution (as the background) and of the diluted standard
were counted sequentially with the plasma samples. The apparent plasma volume (PVa) was com-
puted from the following equation:
al' 3 ' (in sterilized syringes) was purchased from the Ames Division of Miles Laboratories Inc., Elkhart, Indiana.
bEvans Blue was manufactured by General Diagnostics Div., Warner-Chilcott, Morris Plains, N. Y. (5 ml).
3
weight of injected dose, gm \ .
PVa(ml)= T - 7— — . . . f . , . (500ml) (1)av
 ' Ap-Abk / \ weight of standard, gm I v ' v '
where As is the I1 31 radioactivity in the diluted standard, CPM/2 ml; A^, the background radio-
activity, CPM/2 ml; and An the I1 3 1 radioactivity in plasma, CPM/2 ml. The actual plasma volume
was determined by either: (a) the apparent plasma volume measured 10 min after I 1 3 1 injection
was taken as the actual plasma volume or (b) a straight-line fit computed by the method of least
squares using all apparent plasma volumes measured within 2 hours (10, 20, 30, 60, 90, and
120 min). This line was extrapolated to zero time and the extrapolated value (the value a in eq. (2))
was taken as the actual plasma volume. The equation used for the least-squares fit was
2(Y-Y) 2 = 2[Y-(a + bX)]2 (2)
where Y is the apparent plasma volume at any time; Y, the corresponding predicted plasma volume;
X, measurement time; a, the predicted plasma volume at zero time; and b, the slope of the straight
line.
When Evans Blue is injected, it becomes rapidly and preferentially bound to the plasma
albumin. Approximately 5 ml of a 0.5 percent aqueous dye solution was administered intravenously
without further dilution. The exact dose administered, blood sampling, subject management, test
procedure, and preparation of plasma were the same as for the I1 3 ' method. The treatment of the
plasma samples, the determination of their Evans Blue dye concentration, and the subsequent
computation of plasma volume were performed in a way similar to that of O'Brien, Ibbot, and
Rodgerson (ref. 12). The procedure is as follows: (a) The Evans Blue stock standard was prepared
by diluting 1 ml of the commercial (0.5 percent) stock dye preparation to 50 ml with distilled
water, (b) The internal standard was prepared with 0.2 ml of Evans Blue diluted standard solution
mixed with 2 ml of control plasma obtained prior to the injection of the dye. The quantity of Evans
Blue recovered from the plasma mixture was analyzed spectrophotometrically and served as the
internal standard, (c) The internal standard and plasma samples were mixed thoroughly with 1 5 ml
of Teepol-phosphate, a detergent that displaces the dye from protein. The mixture was transferred
gently onto a pulp column prepared with Solka-Floc SW-40A (Brown Co., Boston, Mass.). The
column was rinsed with 5 ml of Teepol phosphate. Interfering substances such as protein, pigments,
and chylomicrons were washed from the column with 2 percent disodium hydrogen phosphate.
With this technique, the interference due to hemolysis can be minimized or eliminated completely.
The flow rate of the eluate in the chromatographic columns was regulated with a stopcock to about
one drop every 2 seconds. The dye was then eluted from the column with a freshly prepared
alkaline acetone-water mixture (1:1) without adjustment of pH. (d) The light absorption of the
plasma blanks, standards and the dye recovered from plasma were measured at 6 1 5 mn with a Zeiss
PMQ II spectrophotometer. (e) The plasma volume was computed from -the following equation:
EBi X estd X V
PV(ml) = - TTT^ -
 v . n- (3)v
 X 1.03
where EBj is the weight of Evans Blue injected (gm); e^, the absorbance of Evans Blue extracted
from the plasma-standard mixture; V, the volume of plasma used for determination (ml); €p\, the
absorbance of Evans Blue extracted from plasma; EBS^, the amount of Evans Blue added to the
internal standard (ml of Evans Blue solution X 1/50 X 0.2); and 1.03, the correction for the
estimated 3 percent Evans Blue absorbed by the tissues.
Total Body Water and Extracellular Fluid Volumes
The total body water and extracellular fluid volumes were measured simultaneously. After the
initial urine and blood collections, approximately 50 ml of a sodium bromide-D2O mixture (2.9 gm
of NaBr in 49 gm of D2O)C was administered orally using a syringe. The exact dose administered
was determined by the difference in weight of the syringe before and after the NaBr-D2 O adminis-
tration. Immediately after ingestion and 2 and 7 hours after ingestion of the NaBr-D2 O mixture,
100 ml of tap water was consumed. Exactly 2, 3, 5, and 8 hours after the ingestion of the tracers,
10-ml blood samples were drawn and processed as described under Plasma Volume. Urine samples
were collected before ingestion and 3 and 8 hours after ingestion of the NaBr-D2 O mixture. All
samples of plasma and urine were kept frozen at -6° C. Chemical analyses and computations of total
body water and extracellular fluid volumes are described below.
Total body water (D2 O space) was determined from the administered dose of D2 O and the
plasma concentration after equilibration in the body. Deuterium oxide in the plasma and urine
samples was recovered by lyophilization and analyzed with a Beckman IR-9 infrared spectropho-
tometer (ref. 13). Matched calcium fluoride cells with 0.9 mm light paths were used for all measure-
ments. Light absorption of each sample at 2,513 cm"1 was determined approximately 5 min after
the cell was placed in the spectrophotometer to allow for temperature equilibration.
A D2 O standard curve was constructed with seven standards ranging from 0.01 to 0.2 ml D2O
per 100 ml of water and the light absorption was read at 2513 cnf1 against distilled water. The
linear curve was fitted to the data by the method of least squares. The result of D2 O analyses
showed that 97.3 to 103.0 percent (mean of 99.7 percent) of the standard added to plasma in vitro
was recovered. The total body water at each period of measurement was computed as follows: (a)
The weight of NaBr was subtracted from the weight of NaBr-D2 O mixture administered, (b) The
D2 O administered was converted from gravimetric (gm) to volumetric units (ml) from:
weight of D2 OX 0.9976D2 O ingested (ml) = - - (4)
where 0.9976 is the purity of D2 O and 1.104 the density of D2O at 22° C. (c) The volume of D2 O
excreted in urine was calculated from:
OD u X[D 2 0] s t d XV u
D2 O excreted (ml) = ~ ^. (5)uustd
°NaBr-D2O solution: 1.5 gm of NaBr in 25 gm of D20, sterile and pyrogen free, was manufactured by
Merck and Co., Inc., Canada.
where ODU and OD^d are the light absorptions of urine and the standard at 2,513 cm ' ; [D2O]st(j
is the concentration of D2O of the standard (in volume percent); and Vu is the total volume of
urine excreted (in ml), (d) The concentration of D2O in plasma [D2O]pj (in volume percent) was
calculated from:
ODplX[D20]s td
(e) The total body water (in liters) was computed from:
T * i u A * n-* x °2 ° ingested ~ Dz ° excretedTotal body water (hters) = -
 [ D 2o ] p lX10 - (7)
(f) The total body water given in the present study was computed from the single measurement of
D2 O concentration in plasma 3 hours after ingestion, and from the serial measurements 2, 3, 5, and
8 hours extrapolated to zero time after D2 O administration, with the curve fitted by the method of
least squares.
Extracellular fluid volume (bromide space) was determined from the plasma concentration of
bromide at equilibrium after the ingestion of a known quantity of NaBr. The bromide concentra-
tion in plasma was determined by the microdiffusion technique of Conway (ref. 14) as modified by
Cheek (ref. 1 5). One ml of plasma was placed in a 1 5-ml clean glass-stoppered tube and, after 1 ml
of distilled water was added, the contents of the tube were dried in an oven at 95° C. Five ml of
distilled water was added to the dry residue and agitated with a Vortex mixer for 1 hour. The tubes
were then centrifuged and a 4-ml aliquot of the clear supernatant was pipetted to the outer chamber
of a pyrex Conway microdiffusion cell. The supernatant was dried at 95° C in the Conway cell and
then ashed at 400° C for 20 min. After cooling, approximately 0.2 gm of potassium dichromate was
added to the outer chamber and 1 ml of 20 percent potassium iodide was added to the inner
chamber. The cell was half closed with a lid lubricated with silicone grease (Dow Corning); after
1 ml of 40 percent sulphuric acid was added to the outer chamber, the cell was closed completely.
The contents of the outer chamber were mixed by rotation. The Conway cell remained at room
temperature for 2 hours so that the complete diffusion of bromide would replace the iodide in the
inner chamber. The liberated iodide in the inner chamber was then titrated with 0.01 N sodium
thiosulfate from a microburette (Manostat Corp., N.Y.), with 0.2 percent starch solution as
the end-point indicator.
Sodium bromide standards, ranging from 0.01 to 2.0 mEq/liter, were prepared with plasma
and analyzed with the same procedure as for the samples. The result of the Br analyses showed that
92.5 to 97.5 percent (mean of 95.0 percent) of the standard added to plasma in vitro was recovered.
A standard curve was constructed from the bromide standards. Bromide space was computed from:
Brj X 0.9 X 0.95 X 0.94
Bromide space (liters) = - 7^r\ (8)[Br]pl
where Brj is the ingested bromide (in mEq); 0.9, the proportion of the bromide remaining in the
plasma (10 percent of the bromide is assumed to enter the red blood cells); 0.95, the Donnan
equilibrium factor; 0.94, the density of the plasma; and [Br]pi, the plasma bromide concentration.
Results were analyzed with the appropriate t-test and the level of significance was a = 0.05.
(Nonsignificant differences are indicated by NS.)
RESULTS AND DISCUSSION
Plasma Volume
The I1 3' albumin spaces measured on nine subjects are shown in table 1. The mean albumin
space measured 10 min after the tracer was administered was 3,347 ml and that obtained from the
TABLE 1.- COMPARISON OF PLASMA VOLUMES USING I 1 3 ' AND EVANS BLUE BETWEEN ONE 10-MIN
POSTINJECT10N SAMPLE AND THE ZERO TIME EXTRAPOLATED VALUE
I 1 3 1 Space
Subject
NP
TA
DL
RK
AO
RR
VC
RS
RR
Mean
1SE
N
5
5
1
5
5
I
1
J
1
0 min
(ml)
3368
2906
4586
3310
3353
3114
3015
3629
2854
3369
175
10 min
(ml)
3417
2930
4590
3194
3367
3085
3014
3664
2864
3347
177
Omin „
10 min X I0°
98.6
99.2
99.9
103.6
99.6
100.9
100.0
99.0
99.7
100.1
.50
Evans Blue space •
Subject
NP
TA
DL
RK
AO
TS
JRo
VC
KN
CH
JRe
TV
Mean
JSE
N
5
5
1
5
5
3
3
3
3
3
3
3
0 min
(ml)
3133
2661
3194
2835
3011
3106
4103
2925
2862
3633
4400
2753
3218
158
10 min
(ml)
3167
2674
3306
2837
3064
3059
3898
2962
2913
3608
4355
2841
3224
143
Omin
10 min X 10°
98.9
99.5
96.6
99.9
98.3
101.5
105.3
98.8
98.2
100.7
101.0
96.9
99.6
•68 , .
extrapolated slope of four measurements during the first hour was 3,369 ml (table 1). The individ-
ual variations of I13 ' spaces in four measurements over an 8-day period were very small; the means
(±SE) were 3,317 ±60 ml for NP, 2,673 ±45 ml for TA, 2,822 ±70 ml for RK, and 3,363 ±165 ml
for AO. The mean percentage difference between the 0-min and the 10-min calculation was
0.1 percent (NS, fig. 1). These results indicate that the short method using the 10-min interval after
I131 is administered is comparable to the extrapolation method involving serial measurements.
Evans Blue space volumes were compared at 10-min postinjection versus the extrapolation
method during the first hour after the tracer was administered (table 1). The individual variations of
Evans Blue spaces in four measurements over an 8-day period were similar to the I1 3' spaces; the
means (±SE) were 3,232 (±101) ml for NP, 2,654 (±61) ml for TA, 2,766 (±85) ml for RK, and
3,142 (±66) ml for AO. The Evans Blue spaces determined by either method on 12 subjects were
3,218 ml for the extrapolated 0-min value and 3,224 ml for the 10-min measurements (NS, fig.2).
The mean percentage difference between the 0-min extrapolation and the 10-min data was
0.4 percent (NS). Thus, Evans Blue space determined from a single sample obtained 10 min after
the tracer is administered is comparable to the zero extrapolation value from serial sampling.
A comparison was made between I 1 3 1 space and Evans Blue space measured simultaneously
(fig. 1 and table 1). In subjects NP and TA, the I 1 3 1 determinations preceded the Evans Blue
measurements, while in subjects RK and AO, Evans Blue space was measured first. Although not
statistically significant, the I 1 3 1 space was consistently larger than the Evans Blue space, varying
from 1 to 7 percent measured by the 10-min technique (NP, 3 percent; TA, 1 percent; PK,
2 percent; AO, 7 percent). Schultz, Hammersten, Heller, and Ebert (ref. 16) and Seer, Allen, and
Gregerson (ref. 9) found that Evans Blue gave slightly higher values (NS) than I1 3 '. Their compari-
sons were made on the basis of single dye and isotope determination on each subject. Zipf, Webber,
and Grove (ref. 8) compared these two tracers on 34 adult males from two independent blood
samples drawn 15 to 20 min after injection. The mean plasma volume determined by Evans Blue
(52.1 ml/kg) was 25.5 percent higher than that obtained with I 1 3 1 (41.5 ml/kg). The Evans Blue
method has a mean probable error of 213ml (5.2 percent) while the I 1 3 1 method yielded an
average probable error of 57 ml (2.3 percent). Zipf et al. concluded that the difference in the results
between the two methods was due to the differences in the inherent errors in the volumetric (Evans
Blue) and gravimetric ( I 1 3 1 ) analytical techniques and not to any intrinsic difference in the bio-
chemical or physiologic characteristics of the two tracers. Crispell et al. (ref. 11) determined the
plasma volume of 19 adult males using I 1 3 1 albumin and Evans Blue dye simultaneously; the I 1 3 '
space in 10 subjects was greater than the Evans Blue space and lower in the other 9 subjects. These
differences were not statistically significant. In the present study I 1 3 ' resulted in a slightly greater
plasma volume than Evans Blue. Two possible explanations are worth mentioning: (a) The discrep-
ancy may be due to the intrinsic difference in the biochemical or physiologic characteristics of the
two substances or (b) some I 1 3 ' in the commercial I 1 3 ' RIHSA may be present as the free iodide
and not tagged onto the serum albumin molecules; thus it could enter the interstitial space during
the first 10 min of the measurement. Loss of tracer after injection would result in a larger calculated
E23 Evans blue space
E23 I Residual tracers
3600
 r
Day I
Figure 1.— Comparison of average I1 3 ' (striped bars)
and Evans Blue spaces (mean ±SE) of simul-
taneous measurements on four subjects. The solid
bars at the bottom represent the residual tracer
(expressed as a percent of total tracer in the
plasma after injection).
Figure. 2.- Comparison of average Evans Blue
spaces of seven subjects measured in three con-
secutive weeks between the 0-min extrapolation
value and that computed from the 10-min
sample. The solid bars at the bottom represent
the residual Evans Blue (expressed as a percent of
total dye after injection).
TABLE 2.-ACCUMULATION OF I1 3 1 R IHSAANDI 1 3 1 R1HSA SPACE FROM REPEATED INJECTIONS
Subject
NP
TA
RK
AO
Mean
±SE
RR
CH
Mean
Group
Day I
Residual
,U1
(CPM)
139
68
50
32
% ('°0)i
0.486
.258
.212
.168
.281
.142
, 131
Space
(ml)
3427
2631
2978
3747
3198
245.6
Day 4
Residual
,131
(CPM)
6640
7722
7270
5720
£l.OO)
42.00
41.94
39.65
38.64
40.56
.84
- I 1 3 1
Space
(ml)
3150
2795
2886
3410
3060
138.8
Day 6
Residual
I131
(CPM)
1 1 ,740
13,908
12,932
10,027
A<-
-2(100)
Al
85.35
80.13
77.06
75.53
79.52
2.17
,131
Space
(ml)
3368
2588
2771
3352
3019
200.0
Day8
Residual
,131
(CPM)
12.779
14,684
13.582
10,853
A
— H. (100)
Al
64.13
60.53
54.61
49.14
57.10
3.30
,13 .
Space
(ml)
3322
2677
2653
2944
2899
155.7
Group 2
Day 1
14
1
.069
.005
.038
2763
3130
2947
Day 3
6854
5938
39.96
47.04
43.50
2272
3774
3023
Day 5
10,230
8,9'l5
39.29
38.69
38.99
2850
3194
3022
Day 7
16,320
14,108
74.68
78.33
76.51
2790
3598
3194
*AQ is the I 1 3 l activity of plasma before injection (CPM/2 ml plasma); A, is the I 1 3 ' activity from injection (CPM/2 nil plasma) (plasma activity at 10-min - plasma
activity at zero time).
plasma volume. Evans Blue has one advantage over I131 as a tracer in that Evans Blue will discolor
the arm at the site of injection if any tracer escapes into the extravascular space.
The effect of I131 buildup on I131 space was determined in four subjects (group 1) who
received I1 31 injections on days 1,3,5, and 7 (table 2). At the beginning of the fourth test (day 8),
the residual I131 activity in the plasma varied from 3.5 to 4.3 pCi and after the fourth injection, it
varied from 8.5 to 9.3 juCi. In group 1 the calculated mean (±SE) plasma volume, determined when
the residual I131 was 75 to 85 percent of the injection dose on day 6, or 3,019 (±200) ml was
essentially the same as the mean plasma volume on day 1 or 3,198 (±246) ml. The variability (±SE)
of the mean plasma volume was lower on days 4, 6, and 8 than on day 1. In group 2, the day 1
mean plasma volume was 3,194ml compared with 2,947 ml on day 1 (NS, table 2). When the
residual radioactivity is accounted for, these results indicate that repeated injections of I13 * every
other day with a total of four injections do not affect the measurement of plasma volume significantly.
The effect of Evans Blue dye buildup on Evans Blue space was measured in four subjects on
days 1, 4, 6, and 8 (group 1) and in seven subjects on days 1,8, and 15 (group 2) (see table 3 and
fig. 2). In group 1, the mean plasma volumes over the eight days varied from 2,979 ml on day 1 to
2,873 ml on day 8, a difference of 3.6 percent. In group 1, the residual Evans Blue concentration is
about 41 percent of the injected dose on day 4, 75 percent on day 6, and 87 percent on day 8, but
the Evans Blue spaces on day 6 and day 8 were only slightly lower than on day 1. A similar decrease
over time was obtained when the plasma volume was measured with I13 ' (table 2). The decline of
Evans Blue space possibly represents a change in plasma volume rather than the effect of Evans Blue
accumulation.
The effect of Evans Blue buildup on the determination of plasma volume in seven subjects at
weekly intervals (table 3, group 2) showed that Evans Blue space on day 15 (3,191 ml) was
TABLE 3.- ACCUMULATION OF EVANS BLUE AND EVANS BLUE SPACE IN REPEATED INJECTIONS
Group 1
Day 1
Subject
NP
TA
RK
AO
Mean
±SE
Residual
Evans Blue
eQ615 m#
0.006
.012
.015
.017
.013
.002
Injected
dose
6i615 m/j
0.120
.169
.150
.117
.139
.012
— X 100*
ej
5.00
7.10
10.00
14.53
9.16
2.06
Evans Blue
Space
(ml)
3532
2476
2600
3308
2979
260
Day 6
NP
TA
RK
AO
Mean
±SE
0.091
.125
.104
.080
.100
.010
0.124
.140
.145
.120
.132
.006
73.39
89.29
71.72
66.67
75.27
4.89
3151
2730
2742
3182
2951
124
Day 4
Residual
Evans Blue
eQ615 mil
0.062
.066
.054
.041
.056
.006
Injected
dose
e,6l 5 nuj
0.122
.147
.141
.132
.136
.005
•y^X 100
50.82
44.90
38.30
31.06
41.27
4.26
Evans Blue
Space
(ml)
3156
2734
3001
3066
2990
92
Day8
0.121
.140
.141
.101
.126
.009
0.132
.153
.151
.140
.144
.005
91.67
91.50
93.38
72.14
87.17
5.03
3087
2674
2720
3011
2873
103
Group 2
Day 1
Subject
TS
JRo
VC
KN
CH
JRe
TV
Mean
±SE
Residual
Evans Blue
eQ615 m/i
0.012
.014
.018
.012
.008
.012
.017
.013
.001
Injected Evans Blue
dose —x 100 Space
6,615 mM f| (ml)
0.109 11.01 3387
.104 13.46 3735
.068 1 1 .76 2906
.142 8.45 2898
.108 7.41 4079
.069 17.39 3983
.086 19.77 2848
.098 12.75 3405
.010 1.71 202
Day 8
Residual
Evans Blue
eQ615 mil
0.053
.036
.024
.031
.024
.026
.035
.033
.004
njected
dose
6|615 mfi
0.129
.166
.134
.130
.097
.136
.122
.131
.008
e
— X 100
e
'
41.09
21.69
17.91
23.85
24.74
19.12
28.69
25.30
2.96
Evans Blue
Space
(ml)
2779
4023
3106
2970
3252
3901
2920
3279
180
Residual
Evans Blue
6Q615 mji
0.046
.039
.044
.043
.033
_
.051
.043
.003
Day 15
Injected
dose
eT615 nvi
0.140
.096
.137
.138
.078
_
.106
.116
.011
e Evans Blue
— X 100 Space
6I (ml)
32.86 3011
40.63 3937
32.12 2875
31.16 2872
42.31 3495
_ _
48.11 2756
37.87 3191
2.80 177
*e0 is the absorbance of Evans Blue extracted from 0-min plasma; 6| is the absorbance of Evans Blue extracted from 10-min plasma - eQ. Evans Blue Space was com-
puted from 10-min plasma sample.
TABLE 4.- 1" 3 ' SPACE AND EVANS BLUE SPACE OF YOUNG HEALTHY MALES
Subject
NP
TA
DL
RK
AO
CH
RR
RC
JR
KS
MT
TD
RW
Mean
±SE
I 1 3
N
4
5
1
5
4
4
5
1
1
1
2
2
2
Mean
(ml)
3198
2834
4590
3048
3064
3425
2852
2610
3532
3817
4168
3330
3141
3355
155
' Space
±SD
188
219
389
295
311
135
194
28
16
197
±SE
94
98
174
132
156
60
138
20
11
98
ml/kg
43.1
42.0
44.4
42.0
32.9
42.7
41.9
46.6
55.2
51.7
57.0
47.7
52.5
46.1
1.84
liter/m2
.68
.57
2.01
.64
.44
.67
.58
2.03
2.00
2.13
1.79
1.78
.07
Evans Blue space
Subject
NP
TA
DL
RK
AO
CH
TS
JRo
VC
KN
JRe
TV
Mean
±SE
N
3
3
1
3
3
3
3
3
3
3
3
3
Mean
(ml)
3167
2585
3306
2837
3064
3608
3059
3898
2962
2913
4355
2841
3216
146
±SD
333
101
314
222
425
307
148
126
51
716
82
257
±SE
192
58
181
128
245
177
85
73
29
413
48
148
ml/kg
42.7
38.4
32.0
39.1
32.9
44.9
42.8
48.0
41.3
41.4
50.5
40.3
41.2
1.55
liter/m2
.67
.43
.45
.53
.44
.76
.67
.85
.59
.57
2.09
1.56
1.63
.06
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6.3 pe rcen t lower t h a n on day 1
(3 ,405ml) , with the day 8 value in
between. Again there is a decrease of Evans
Blue space with time as in group 1. These
results indicate that Evans Blue buildup
does not interfere appreciably with the
measurement of Evans Blue space when it
is administered four times in 8 days or
three times in 15 days.
To determine if Evans Blue interferes
with the measurement of I 1 3 1 space and
the latter with Evans Blue space, one tracer
was injected at zero time and four blood
samples were than obtained 10, 20, 30, and
60 min thereafter. At 60 min, the second
tracer was injected and four more blood
samples were then withdrawn at 70, 80, 90,
and 120 min. The slope of the 0- to 60-min
tracer measurements was compared with
the slope of the second tracer measure-
ments. The two slopes were very similar
regardless of which tracer was injected first
(fig. 3). Thus, it is concluded that the
Evans Blue and I1 31 do not interfere with
each other and the two substances may be
used interchangeably for daily plasma
volume determination.
4000
 r
3500
«,- 3000
i 2500
2000
( o )
Evans blue
4000r
3500
,; 3 ooo
g 2500
2000
( b )
Evans blue
20 40 60 80
Time, min
100 120 140
(a) Each point represents the mean (±SE) of three tests
on two subjects.
(b) Each point represents the mean (±SE) of two tests,
on each of two subjects.
Figure 3.— Least-squares curves of sequential measurements
of I1 3 ' and Evans Blue spaces.
Interindividual variability in plasma
volume was measured in 13 subjects with
I131 and 12 subjects with Evans Blue
(table 4); some subjects were used for both
measurements. The mean (±SE) for the
I 1 3 1 space were 3,335 (±155) ml, 46.1
(±1.84) ml per kilogram body weight and
1.78 (±0.07) liter/m2 of body surface; the
means (±SE) for Evans Blue space were 3,216 (±146) ml, 41.2 (±1.55) ml per kilogram of body
weight, and 1.63 ±0.06 liter/m2 of body surface. Average intraindividual variability (±SE) was
±98 ml for I1 3 ' space and ±148 ml for Evans Blue space. The difference in the means of the plasma
volume measured by the two methods was not statistically significant.
The plasma volumes, ranging from 2,610 to 4,590ml (I1 3 1 method) and from 2,585 to
4,355 ml (Evans Blue method, table 4), were in good agreement with the findings of Crispell^
Porter, and Nieset (ref. 11) who reported plasma volumes from 2,232 to 3,860 ml by I 1 3 ' albumirt
measurement and from 2,120 to 3,800 ml by Evans Blue measurement. Similarly, Myhre, Brown,
Hall, and Dill (ref. 17) found that the plasma volumes of normal subjects varied from 2,120 t6
3,610 ml (Evans Blue method). Hansen (ref. 18) reported plasma volumes from 2,439 to 3,041 ml
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by I 1 3 1 albumin measurement. The mean Evans Blue space of the 12 subjects in this study was
3,216 ±146 ml (table 4), which compares favorably with the 3,106 ±402 ml found by Retzlaff,
Tauxe, Kiely, and Stroebel (ref. 19). ;
Extracellular Fluid Volume
The extracellular fluid space of the body was calculated from the bromide concentration in
plasma after equilibration and the quantity excreted in urine. It should be stressed that the bromide
space probably measures a volume greater than the true extracellular fluid volume because bromide
is incompletely removed from the alimentary tract (2 to 3 percent residual) and because it is not;
entirely an extracellular ion, for example, it is present in red blood cells (approximately 3 to
5 percent).
The distribution of the bromide ion in the body 8 hours after administration is similar to that
of the chloride ion distribution, except that bromide slowly penetrates the central nervous system.
The ratio of BR82 to Cl in the cerebral spinal fluid is only about a third of that in plasma (ref. 3);
Although bromide and chloride ions are
halogens, the various cells handle them
differently. The BR82 space is about
2 percent higher than the Cl3 8 space 2
1/2 hours after the isotopes are given
intravenously, even though there is a
greater concentration of BR8 2 than
C13 8 in the upper part of the alimentary
tract and in the saliva (ref. 20). On the
contrary, the kidney excretes chloride in
preference to bromide (ref. 21). These
findings suggest that bromide and
chloride are not completely interchange-
20
15
10
Residual tracers
able when
volume.
used for measuring ECF
Time, min 0 180
Week I
Figure 4.— Comparison of average bromide spaces in seven
subjects measured in three consecutive weeks between the
0-min extrapolation value and that computed from the
180-min sample. The solid bars at the bottom represent the
residual bromide (expressed as a percent of the total
bromide after ingestion).
In the present study bromide space
was measured by zero time extrapolation
and from the single determination of the
3-hr sample. The mean values of extra-
cellular fluid space determined by both,
methods (0 min vs. 180 min) were
essentially constant (fig. 4). The mean
(±SE) extracellular fluid volumes werp
15.6 (±0.20) liters by extrapolation and
15.8 (±0.17) liters for the 180-min measurement (NS). The consistency of these results indicates
t'hat uniform distribution of bromide in the extracellular space was achieved within 3 hours. '
The effect of bromide buildup on consecutive extracellular volume measurements was mea-
sured in seven subjects once each week for three consecutive weeks (table 5). (Bromide retained in
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TABLE 5.- RESIDUAL BROMIDE AND THE BROMIDE SPACE IN REPEATED MEASUREMENTS
3 HOURS AFTER 1NGESTION
Subject
CH
TS
JRo
VC
KN
JRe
TV
Mean
±SE
Residual
bromide
(Br]o*
(mEq/liter)
Ingested
dose
[Br]3 - [Br]0
(mEq/liter)
[Br) 0 ( iOO)
[Br] 3-[Br) 0
(percent)
Bromide space
liter liter/kg liter/Hi2
Week 1
0.0
.0
.0
.0
.0
.0
.0
.0
.0
.33
.43
.44
.50
.40
.35
.49
1.42
.02
CH
TS
JRo
VC
KN
JRe
TV
Mean
±SE
.65
.70
.70
.79
.70
.68
.49
.67
.03
.38
.48
.40
.55
.59
.37
.47
1.46
.03
0.0
.0
.0
.0
.0
.0
.0
.0
.0
17.00
15.78
16.00
15.25
15.03
16.92
15.52
15.94
.30
0.21
Tl
.20
.21
.21
.20
.22
.21
.00
8.34
8.62
7.58
8.20
8.08
8.13
8.53
8.21
.13
Week 2
47.1
47.3
50.0
51.0
44.0
49.6
33.3
46.0
2.3
16.60
15.30
16.12
14.60
14.50
—
15.20
15.39
.34
.21
.21
.20
.20
.21
—
.22
.21
.00
8.10
8.36
7.64
7.85
7.80
7.96
8.35
8.01
.10
Week3
CH
TS
JRo
VC
KN
JRe
TV
Mean
±SE
1.08
.66
1.05
1.18
.83
.75
.75
.89
.08
.28
.47
.46
.52
.54
.42
.45
1.45
.03
84.4
44.9
71.9
77.6
52.6
51.4
51.7
62.1
5.9
17.40
15.60
15.70
14.90
14.90
16.20
15.70
15.77
.32
.22
22
.20
.21
.21
.19
.22
.21
.01
8.49
8.52
7.44
8.01
8.01
7.79
8.63
8.13
.17
*[Br]0 is the plasma bromide concentration before bromide admistration; [Br]3 is the plasma bromide concentrat ion
3 hours after bromide admistration: Bromide space was determined from the 3-hr bromide concentration in plasma.
the body was expressed as a percent of the injected dose.) The buildup of plasma bromide was
46 percent of the ingested dose in week 2 and 62.1 percent of the ingested dose in week 3. In week
3, the residual bromide level was about 39 percent of the total plasma bromide concentration. This
buildup of bromide in the plasma had no effect on the measurement of bromide space in three
weekly determinations (fig. 4, table 5).
The average total bromide concentration in the body in the third week, including the residual
bromide, ranged from 2.15 to 2.70 mEq/liter, well within the accepted tolerance level of
13 mEq/liter or 1 gm/liter. These results indicate that bromide space can be measured accurately in
three consecutive weekly determinations.
Interindividual variability of bromide space in seven subjects ranged from 14.8 to 17.0 liters.
The means (±SE) were 15.8 (±0.31) liters, 0.208 (±0.004) liter per kilogram body weight, and 8.12
(±0.13) liters/m2 body surface (fig. 4). Average intraindividual variability (±SE) was ±170 ml. These
13
Residual tracers
Figure 5.— Comparison of average deuterium oxide spaces
in seven subjects measured in three consecutive weeks
between the 0-min.extrapolation value and that compu-
ted from the 180-min sample. The solid bars at the
bottom represent the residual deuterium (expressed as a
percent of the total deuterium after ingestion).
.4r-
Urinary D20 = 0.004 + 1,053 (Plasma D20)
Q TV
0 .1 .2 .3 .4
3-hr Plasma D20, ml/100 ml
Figure 6.- Regression of the deuterium oxide concentra-
tions in plasma and urine in the 3-hr postingestion sam-
ples in eight subjects. The solid line was fitted by the
method of least squares and the regression equation is
urinary D20 = 0.004 + 1.053 (plasma D2O). The dot-
ted line is the line of identity.
values for bromide space were higher than
the mean sulfate space on 11 healthy males
(13.4 (±1.5) liters and 0.191 (±1.7) liters
per kilogram body weight) reported by
R y a n , Pascal, Inoye, and Bernstein
(ref. 22); however, they are lower than the
mean bromide space of three laboratory
workers (18.6 liters and 0.252 liter per
kilogram body weight) reported by Cheek
(ref. 15). There is no apparent explanation
for the relatively low values of this study
since an average of 95 percent bromide
added in vitro into plasma was recovered.
This suggests that the values found in this
study are possibly closer to the actual
extracellular space.
Total body water — D2O space was
calculated from the 180-min plasma con-
centration and by extrapolating to zero
time the 2-, 3-, 5-, and 8-hr plasma samples.
The mean D2 O space for the seven subjects
for the average of the three measurements
taken one, week apart was 54.1 liters for
the 0-min ^extrapolation calculation and
54.0 liters for the 180-min calculation
(fig. 5). Reliable measurements of D2O
space using one 180-min sample depend on
total equilibration of D2O with total body
water within 3 hours; the consistent plasma
and urinary D2O concentrations confirm
equilibration at 3 hours (fig. 6). These
results indicate that D2 O space determined
from one 180-min sample is as accurate
as the zero time extrapolation.
The effect of D2 O buildup on con-
secutive total body water measurements is
presented in figure 5. In week 3, the
r e s i d u a l D2 O c o n c e n t r a t i o n was
104 percent of the following ingested dose
and 50 percent of the total D2 O concentra-
tion in plasma after ingestion of the new
dose, but this high background had no sig-
nificant effect on the measurement of D2 O
space (table 6). Both 0-min and 180-min
levels were essentially constant over the
three weeks. Thus, there is no significant
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TABLE 6.- RESIDUAL D2O AND TOTAL BODY WATER SPACE IN REPEATED MEASUREMENTS
3 HOURS AFTER INGESTION
Subject
Residual
[D20]0 .
( m l / l O O m l )
Ingested dose
(D20]3-[D20]0
(ml/100 ml)
jfa>
[D,010X 100
[D20]3-[D,0]0
(percent)
Total body water space
liter
percent
body weight liters/m
2
Week 1
CH
TS
JRo
VC
KN
JRe
TV
Mean
,±SE
0.002
- .006
.008
.000
.006
.000
.008
.003
.002
0.075
.090
.060
.070
.078
.071
. .097
.077
.005
2.67
6.67
13.33
.00
7.69
.00
8.25
5.52
1.85
58.91
49.64
58.24
56.73
50.91
61.26
44.65
54.33
2.28
73.36
69.42
71.72
79.01
72.41
70.98
63.33
71.46
1.77
28.74
27.13
27.60
30.50
27.37
29.45
24.53
27.90
.73
Week 2
CH
TS
JRo
VC •
KN
JRe
TV
Mean
*SE
.05]
.064
.058
.060
.056
.039
.060
.055
.003
.075
.084
.041
.079
.087
.072
.092
.076
.006
68.00
76.19
141.46
75.95
64.37
54.17
65.22
77.91
10.97
57.28
50.87
55.07
50.76
60.91
46.25
53.52
2.15
71.33
71.14
-
76.69
72.20
70.57
65.60
71.26
1.45
27.94
27.80
29.61
27.29
29.28
25.41
27.89
.62
Week 3
CH
TS
JRo
VC
KN
JRe
TV
Mean
iSE
.088
.086
.096
.098
.086
.069
.088
.087
.004
.081
.089
.079
.077
.092
.064
.094
.082
.004
108.64
96.63
121.52
106.52
93.48
107.81
93.62
104.03
3.85
53.23
49.23
55.53
56.18
47.25
67.59
46.20
53.60
2.76
66.28
68.93
68.38
78.24
67.21
78.31
65.53
70.41
2.08
25.97
26.93
26.32
30.20
25.40
32.50
25.38
27.53
1.04
interference for the measurement of D2O space at weekly intervals even though there was a
50 percent buildup of residual deuterium oxide. Note that the clearance rate of D2 O in our subjects
varied from 3.7 to 6.3 percent per day (table 7).
Interindividual variability of total body
water in seven subjects ranged from 45.7 to
63.3 liters, and the mean D2O spaces (±SE)
were 54.1 (±2.3) liters, 71.2 (±4.0) liters per
k i l o g r a m body weight, and 27.9
(±0,7) liters/m2 body surface (fig. 5). Average
intraindividual variability (±SE) was
±0.87 liter. The results of this study agree
with those of Moore (ref. 1) who found a
mean D2O space of 47.8 liters (72% of body
weight) in normal adults from plasma samples
taken 2 hours after intravenous injection of
D2 O. Other investigators (refs. 23-26) have
TABLE 7.- D2O CLEARANCE RATE
Subject
RR
CH
CH
CH
TS
VC
KN
JRe
TV
Duration between
measurements
(day)
2
7
9
2
7
7
7
7
7
Clearance rate (percent per day)
5.0,5.5,8.3
4.9, 4.5
5.1
6.6, 4.4
4.7, 6.0
3.2,4.2
4.7, 5.6
6.3,5.1
6.1,6.0
Mean
6.3
4.7
5.1
5.5
5.4
3.7
5.2
5.7
6.1
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reported lower normal values for total body water. For instance, Edelman and co-workers (ref. 24)
found mean total body water levels of 44.1 liters, 61.1% of body weight, and 23.3 liters/m2. One
possible explanation for our apparently higher values compared with those of other investigators is
that most of our subjects were athletic young men who probably had greater lean body masses and
consequently greater total water content. Pascale and co-workers (ref. 27) reported that after three
weeks of paratrooper training, the mean intracellular water and total body water volumes of 12 men
increased 5 to 7 percent. It appears that there is an increase in the water content of muscles induced
by physical training (ref. 28).
CONCLUSIONS
The purpose of this study was to compare the use of Evans Blue with I131-,'for measuring
plasma volume and to determine the reproducibility of bromide and deuterium oxide;for measuring
extracellular fluid volume and total body water volume, respectively. From these results the follow-
ing conclusions are drawn:
(a) Both Evans Blue space and I 1 3 1 space, determined from a single sample obtained
10 min after injection, were comparable with the zero time extrapolation values determined from
serial sampling.
(b) A total of four injections of I 1 3 ' on alternate days, resulting in the residual radiation
buildup of 85 percent of one dose, does not significantly affect the accuracy of measurement of
I 1 3 ' space.
(c) A total of four injections of Evans Blue on alternate days, resulting in the residual dye
buildup of 87 percent of one dose, does not significantly affect the accuracy of measurement of
Evans Blue space.
(d) Evans Blue and I13 ' do not interfere with each other when the two tracers are used
interchangeably for determining plasma volume and the results for both are comparable.
(e) Average interindividual variability (±SE) was ±155 ml for I 1 3 1 space and ±146 ml for
Evans Blue space; average intraindividual variability (±SE) was ±98 ml for I 1 3 1 space and ±148.ml
for Evans Blue space.
(f) Both bromide space and deuterium oxide space, determined from a single sample
obtained 180 min after the tracer was ingested, were comparable with the zero time extrapolation
values determined from serial sampling.
(g) The ingestion of sodium bromide once each week for three consecutive weeks, result-
ing in the residual tracer buildup of 46 percent of one dose, does not significantly affect the
accuracy of measurement of bromide space.
(h) Average interindividual variability (±SE) in bromide space was ±310 ml; average
intraindividual variability (±SE) was ±170 ml.
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(i) Ingestion of deuterium oxide once each week for three consecutive weeks, resulting in
the residual tracer buildup of 104 percent of one dose, does not significantly affect the accuracy of
measurement of D2 O space.
(j) Average interindividual variability (±SE) in total body water was ±2300 ml; average
intraindividual variability (±SE) was ±870 ml.
Ames Research Center
National Aeronautics and Space Administration
Moffett Field, Calif., 94035, Oct. 25, 1972
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